Last update 08 May 2025

Talactoferrin alfa(Agennix AG)

Overview

Basic Info

Drug Type
Recombinant protein
Synonyms
Apolactoferrin(Agennix), TLF(Agennix), Talactoferrin alfa(Agennix)
+ [3]
Target-
Action
modulators, stimulants
Mechanism
Immunomodulators, Macrophages stimulants
Active Indication-
Originator Organization
Active Organization-
Inactive Organization
License Organization-
Drug Highest PhaseSuspendedPhase 3
First Approval Date-
RegulationOrphan Drug (United States)
Login to view timeline

Structure/Sequence

External Link

KEGGWikiATCDrug Bank
D05991--

R&D Status

10 top R&D records.
Login
to view more data
IndicationHighest PhaseCountry/LocationOrganizationDate
Non-Small Cell Lung CancerPhase 3
Malaysia
01 Nov 2008
Non-Small Cell Lung CancerPhase 3
France
01 Nov 2008
Non-Small Cell Lung CancerPhase 3
Turkey
01 Nov 2008
Non-Small Cell Lung CancerPhase 3
Spain
01 Nov 2008
Non-Small Cell Lung CancerPhase 3
Russia
01 Nov 2008
Non-Small Cell Lung CancerPhase 3
India
01 Nov 2008
Non-Small Cell Lung CancerPhase 3
Latvia
01 Nov 2008
Non-Small Cell Lung CancerPhase 3
Greece
01 Nov 2008
Non-Small Cell Lung CancerPhase 3
United Kingdom
01 Nov 2008
Non-Small Cell Lung CancerPhase 3
United States
01 Nov 2008
Login to view more data

Clinical Result

Indication
Phase
Evaluation
View All Results
Study
Phase
PopulationAnalyzed EnrollmentGroupResultsEvaluationPublication Date
Phase 1/2
120
srntyhtaiq(fhshfyocfx) = vgbaxsemgb igxtfcqnhs (koyortlcpn )
Positive
01 Aug 2016
Placebo
srntyhtaiq(fhshfyocfx) = iupnafvbwn igxtfcqnhs (koyortlcpn )
Phase 2/3
305
(taysyqwikg) = xziykuxxsd ysssdvmkri (nreuwkldiu )
Negative
01 Sep 2015
Placebo
(taysyqwikg) = hhlqetwwoi ysssdvmkri (nreuwkldiu )
Phase 2
100
(tgzgrbgkmu) = cpejtfjyqf fejlantptz (iyngaladnr )
-
20 May 2011
Placebo
(tgzgrbgkmu) = xsqvbmcmfo fejlantptz (iyngaladnr )
Phase 2
100
(vguimbudqk) = hzfkasfrcx rmubfazuep (pxknlpovbv )
Positive
20 Jun 2007
Phase 2
-
(iwvwvcfjwh) = wcjmnesjjc maoooejfwn (yuiifdzfih )
-
20 Jun 2006
Login to view more data

Translational Medicine

Boost your research with our translational medicine data.
Boost your research with our translational medicine data.

Deal

Boost your decision using our deal data.
Boost your decision using our deal data.

Core Patent

Boost your research with our Core Patent data.
Boost your research with our Core Patent data.

Clinical Trial

Identify the latest clinical trials across global registries.
Identify the latest clinical trials across global registries.

Approval

Accelerate your research with the latest regulatory approval information.
Accelerate your research with the latest regulatory approval information.

Biosimilar

Competitive landscape of biosimilars in different countries/locations. Phase 1/2 is incorporated into phase 2, and phase 2/3 is incorporated into phase 3.
Competitive landscape of biosimilars in different countries/locations. Phase 1/2 is incorporated into phase 2, and phase 2/3 is incorporated into phase 3.

Regulation

Understand key drug designations in just a few clicks with Synapse.
Understand key drug designations in just a few clicks with Synapse.
Chat with Hiro
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free